Literature DB >> 1693846

In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV).

P M Rwambo1, C J Issel, K A Hussain, R C Montelaro.   

Abstract

A neutralization escape mutant (A/1 E) of equine infectious anemia virus was isolated after 13 passages in cell culture in the presence of serum containing antibodies to type- and group-specific determinants of EIAV envelope glycoproteins. Loss of neutralization by the selecting serum correlated with loss of two epitopes in the major envelope glycoprotein gp90 of A/1 E which were present in a parallel variant isolated from a persistently infected pony.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1693846     DOI： 10.1007/bf01311062

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  11 in total

1.  Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV.

Authors:  S L Payne; F D Fang; C P Liu; B R Dhruva; P Rwambo; C J Issel; R C Montelaro
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

2.  Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.

Authors:  K A Hussain; C J Issel; K L Schnorr; P M Rwambo; R C Montelaro
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

3.  Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus.

Authors:  R C Montelaro; B Parekh; A Orrego; C J Issel
Journal:  J Biol Chem       Date:  1984-08-25       Impact factor: 5.157

4.  Virulence and in vitro growth of a cell-adapted strain of equine infectious anemia virus after serial passage in ponies.

Authors:  A Orrego; C J Issel; R C Montelaro; W V Adams
Journal:  Am J Vet Res       Date:  1982-09       Impact factor: 1.156

5.  Course and extent of variation of equine infectious anemia virus during parallel persistent infections.

Authors:  S L Payne; O Salinovich; S M Nauman; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

Review 6.  Equine infectious anemia virus: immunopathogenesis and persistence.

Authors:  W P Cheevers; T C McGuire
Journal:  Rev Infect Dis       Date:  1985 Jan-Feb

7.  Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.

Authors:  O Salinovich; S L Payne; R C Montelaro; K A Hussain; C J Issel; K L Schnorr
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

8.  Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.

Authors:  P M Rwambo; C J Issel; W V Adams; K A Hussain; M Miller; R C Montelaro
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

9.  Equine infectious anemia virus: development of a simple reproducible method for titrating infectivity of the cell-adapted strain.

Authors:  G F Amborski; G Jeffers; R L Amborski; C J Issel
Journal:  Am J Vet Res       Date:  1979-02       Impact factor: 1.156

10.  Genomic alterations associated with persistent infections by equine infectious anaemia virus, a retrovirus.

Authors:  S Payne; B Parekh; R C Montelaro; C J Issel
Journal:  J Gen Virol       Date:  1984-08       Impact factor: 3.891
View more
  21 in total

1.  Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.

Authors:  S A Hammond; F Li; B M McKeon; S J Cook; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins.

Authors:  Chungwon Chung; Robert H Mealey; Travis C McGuire
Journal:  Virology       Date:  2004-09-15       Impact factor: 3.616

3.  Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.

Authors:  S M Harrold; S J Cook; R F Cook; K E Rushlow; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.

Authors:  Chungwon Chung; Robert H Mealey; Travis C McGuire
Journal:  Virology       Date:  2005-09-01       Impact factor: 3.616

5.  Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus.

Authors:  Jodi K Craigo; Corin Ezzelarab; Ronald C Montelaro
Journal:  J Virol Methods       Date:  2012-07-20       Impact factor: 2.014

6.  Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.

Authors:  Xiue Han; Ping Zhang; Wei Yu; Wenhua Xiang; Xiaodong Li
Journal:  Virus Genes       Date:  2016-08-29       Impact factor: 2.332

7.  Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.

Authors:  D L Lichtenstein; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses.

Authors:  Yun Li; Bradley Cleveland; Igor Klots; Bruce Travis; Barbra A Richardson; David Anderson; David Montefiori; Patricia Polacino; Shiu-Lok Hu
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

9.  Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.

Authors:  Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

10.  Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein.

Authors:  R F Cook; S L Berger; K E Rushlow; J M McManus; S J Cook; S Harrold; M L Raabe; R C Montelaro; C J Issel
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.